Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $53.54M in the quarter ending March 31, 2026, a decrease of -6.61%. This brings the company's revenue in the last twelve months to $232.40M, up 25.69% year-over-year. In the year 2025, Akebia Therapeutics had annual revenue of $236.20M with 47.46% growth.

• Revenue (ttm): $232.40M
• Revenue Growth: +25.69%
• P/S Ratio: 1.06
• Revenue / Employee: $1,197,959
• Employees: 194
• Market Cap: 251.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	236.20M	76.02M	47.46%
Dec 31, 2024	160.18M	-34.44M	-17.70%
Dec 31, 2023	194.62M	-97.86M	-33.46%
Dec 31, 2022	292.48M	80.83M	38.19%
Dec 31, 2021	211.65M	-82.99M	-28.17%
Dec 31, 2020	294.64M	-40.36M	-12.05%
Dec 31, 2019	335.00M	127.26M	61.26%
Dec 31, 2018	207.74M	26.52M	14.63%
Dec 31, 2017	181.23M	179.69M	11,706.32%
Dec 31, 2016	1.54M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error